Tectonic Therapeutic | AVRO - Cash And Equivalent


Tectonic Therapeutic reported $236.89M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Akebia Therapeutics USD 155.55M 7.1M Jun/2026
Alnylam Pharmaceuticals USD 1.71B 2.46M Jun/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 110.55M 517.12M Jun/2026
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Gilead Sciences USD 7.63B 64M Mar/2026
Ionis Pharmaceuticals USD 350.06M 1.57B Jun/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Karyopharm Therapeutics USD 90.85M 30.31M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
MacroGenics USD 113.91M 47.39M Jun/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pfizer USD 976M 727M Jun/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
Qiagen NV USD 646.29M 192.72M Mar/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sanofi EUR 6.35B 806M Jun/2026
Sarepta Therapeutics USD 571.15M 106.7M Jun/2026
Sartorius EUR 291M 282.8M Jun/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Takeda JPY 460.98B 134.07B Jun/2026
Tilray USD 264.83M 43.16M Jun/2025
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026